-
Location
-
Vancouver
-
Fiscal year end
-
30 September
ESSA Pharma Inc. has filed 513 SEC EDGAR filings since 24 Feb 2015
| Form type |
Sec Links |
Description |
Filing date |
Reporting date |
| SC 13D |
Report
|
|
08 Nov 2024 |
|
| SC 13D/A |
Report
|
SC 13D/A |
12 Jan 2022 |
|
| SC 13D/A |
Report
|
AMENDMENT NO. 3 TO SCHEDULE 13D |
06 Sep 2019 |
|
| SC 13D/A |
Report
|
SC 13D/A |
15 Jul 2019 |
|
| SC 13D |
Report
|
SC 13D |
23 May 2019 |
|
| SC 13D |
Report
|
SC 13D |
13 Feb 2019 |
|
| SC 13D/A |
Report
|
AMENDMENT NO. 2 TO SCHEDULE 13D |
11 Jan 2019 |
|
| SC 13D/A |
Report
|
SC 13D/A |
19 Jun 2018 |
|
| SC 13D/A |
Report
|
|
25 Mar 2016 |
|
| SC 13D/A |
Report
|
|
25 Mar 2016 |
|
| SC 13D |
Report
|
SC 13D |
26 Jan 2016 |
|
| SC 13D |
Report
|
|
25 Jan 2016 |
|
| SC 13D |
Report
|
|
25 Jan 2016 |
|
| SC 13D |
Report
|
SCHEDULE 13D |
25 Jan 2016 |
|
| SC 13D |
Report
|
SCHEDULE 13D |
25 Jan 2016 |
|